P.-Y. Bondiau

Centre Antoine Lacassagne

Papers

3

Total Citations

75

H-Index

3

About

Dr. P.-Y. Bondiau is a leading figure in stereotactic robotic radiotherapy, with a career focused on advancing the precision and safety of CyberKnife treatments. His research centers on the technical optimization and clinical application of this non-invasive technology, particularly for pulmonary and prostate cancers. Bondiau’s seminal 2007 paper, “Radiothérapie stéréotaxique robotisée par CyberKnife®: aspects techniques et indications,” has garnered 46 citations, establishing foundational protocols for robotic radiosurgery. He further demonstrated clinical impact through his 2008 analysis of early toxicity in lung cancer patients treated with CyberKnife (17 citations), providing critical safety data that shaped treatment planning. His work on prostate cancer, detailed in a 2007 study (12 citations), expanded the modality’s applications. Bondiau’s contributions have been instrumental in refining dose delivery, reducing side effects, and broadening indications for robotic radiotherapy, making him a key reference for clinicians and researchers exploring high-precision cancer treatments.

Research Focus

Key Achievements

3
H-Index
3
Papers
75
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Radiothérapie stéréotaxique robotisée par CyberKnife®: aspects techniques et indications
46 citations · 2007
📈 Most Prolific Year: 2007 (2 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Centre Antoine Lacassagne

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago